 The recording from Dr. Berman's podcast interview can be found at Business Innovators Radio Network site here.
During the interview he shares:
0 Comments
|
Dr. BermanRelevant research and clinical insights from our work. Archives
October 2018
|
RSS Feed
This is the new 1070nm transcranial photobiomodulation system developed by Quietmind Foundation (QMF) and based
on the clinical trials that were conducted at Baylor Research Institute and QMF with 100 subjects with mild-moderate
Alzheimer's disease. We have modified the technology to allow for more control over pulse frequency and intensity of light
being delivered. The unit is available for purchase now at https://www.quietmindfdn.org/store/p15/Transcranial-Light-Therapy-System.html
on the clinical trials that were conducted at Baylor Research Institute and QMF with 100 subjects with mild-moderate
Alzheimer's disease. We have modified the technology to allow for more control over pulse frequency and intensity of light
being delivered. The unit is available for purchase now at https://www.quietmindfdn.org/store/p15/Transcranial-Light-Therapy-System.html
This is the Cognitolite unit that we've been using for 15 years to help people reduce cognitive and behavioral symptoms associated with
neurodegenerative disorders including Alzheimer's and Parkinson's disase. These units are available to people who are prepared to join
a longer-term (2 year) clinical trial and pay an equipment fee of $10,000. Subjects will be assessed quarterly using Quantitative EEG and
neuropsychological testing to monitor progress. Details are available by calling Dr. Berman at 610-940-0488.
neurodegenerative disorders including Alzheimer's and Parkinson's disase. These units are available to people who are prepared to join
a longer-term (2 year) clinical trial and pay an equipment fee of $10,000. Subjects will be assessed quarterly using Quantitative EEG and
neuropsychological testing to monitor progress. Details are available by calling Dr. Berman at 610-940-0488.